Thomas (Tom) Pike
CEO
Executive changes
-
Appointed president and chief executive officer of its Drug Development Clinical Development business unit at Labcorp Holdings Inc. (LH)2023-01-09
Earnings-call appearances
No earnings-call appearances recorded yet.